Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
09/2005
09/20/2005US6946263 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/20/2005US6946262 Comprises membrane protein for treatment and diagnosis of cell proliferative disorders; antitumor/anticarcinogenic agents
09/20/2005US6946261 gene expression cassettes comprising promoters joined to nucleic acids that code fusion proteins; peptide antibiotics; genetic engineering
09/20/2005US6946259 Compositions and methods for treating cells having double minute DNA
09/20/2005US6946257 Patched genes and uses related thereto
09/20/2005US6946256 Cell regulatory genes, encoded products, and uses related thereto
09/20/2005US6946253 Azodicarbonamide ejects zinc bound to protein; solid phase synthesis; nuclear magnetic resonance
09/20/2005US6946244 Detecting the activity of orphan G Protein Receptor 86 by incubating a sample comprising GPR86 and adenosine diphosphate (ADP) under binding conditions for both and detecting a second messanger; screening for a modulator
09/20/2005US6946135 Prevention and treatment of amyloidogenic disease
09/20/2005US6946134 improved shelf-life; produced in glycosylation-/protease-free yeast cultures
09/20/2005US6946133 Prostate specific antigen oligo-epitope peptide
09/20/2005US6946132 Pure dnaJp1 peptide in a carrier; dnaJ is a heat shock protein; also immunoassay for identifying persons who are predisposed to develop rheumatoid arthritis
09/20/2005CA2319703C Growth differentiation factor-8
09/20/2005CA2261578C Gene expression regulatory dna, expression cassette, expression vector and transgenic plant
09/20/2005CA2189882C Papillomavirus vaccines
09/15/2005WO2005085867A2 Screening method for emulators of neural activity and digestive system using gpr35
09/15/2005WO2005085866A1 Screening assay for modulators of interaction between interleukin-12 and/or -23 with their receptors
09/15/2005WO2005085861A2 Nucleic acids and encoded polypeptides for use in liver disorders and epithelial cancer
09/15/2005WO2005085860A2 New proliferation markers in clinical practice and their use for cancer prognosis or diagnosis
09/15/2005WO2005085478A2 Detection and identification of mycobacterium and nocardia using primers and probes directed to the seca1 gene
09/15/2005WO2005085472A2 Diagnostic and therapeutic use of mal2 gene and protein for neurodegenerative diseases
09/15/2005WO2005085453A2 Seeds
09/15/2005WO2005085448A2 Canine ghrh gene, polypeptides and methdos of use
09/15/2005WO2005085445A1 Recombinant varicella-zoster virus
09/15/2005WO2005085444A1 Chithin oligosaccharide elicitor-binding protein
09/15/2005WO2005085441A1 Modified promoter
09/15/2005WO2005085438A1 Transgenic nonhuman mammal representing the pathologic conditions of human rheumatoid arthritis
09/15/2005WO2005085433A1 Method of regulating o-glycosylation in eucaryotic cell
09/15/2005WO2005085419A1 L-glutamic acid-producing microorganism and a method for producing l-glutamic acid
09/15/2005WO2005085417A2 Bacterial system for protein transport in eukaryotic cells
09/15/2005WO2005085287A1 Treatments for contaminant reduction in lactoferrin preparations and lactoferrin-containing compositions
09/15/2005WO2005085286A2 Peptides with antiangiogenic and antitumor activities
09/15/2005WO2005085285A2 Nuclear hormone receptors
09/15/2005WO2005085284A1 Il-4/il-13 sepecific polypetides and therapeutic uses thereof
09/15/2005WO2005085283A1 Modified interleukin-11 and medicinal composition containing the same
09/15/2005WO2005085282A1 Il-15 binding site for il15-ralpha and specific il-15 mutants having agonists/antagonists activity
09/15/2005WO2005085281A1 Mutein of a bone morphogenetic protein and use thereof
09/15/2005WO2005085280A2 HUMAN cDNA CLONES COMPRISING POLYNUCLEOTIDES ENCODING POLYPEPTIDES AND METHODS OF THEIR USE
09/15/2005WO2005085279A1 Stress-inducible osasr1 gene and protein enhancing tolerance to abiotic stress
09/15/2005WO2005085278A1 Fusion proteins comprising modified allergens of the ns-ltps family, use thereof and pharmaceutical compositions comprising the same
09/15/2005WO2005084707A1 Method of utilizing organic cation transporter oct3-related molecule for treating mental diseases such as depression, anxiety neurosis, drug addiction and the like
09/15/2005WO2005084691A1 Method of proliferating precursor cells
09/15/2005WO2005084444A1 Compositions and methods for the treatment and clinical remission of psoriasis
09/15/2005WO2005084427A1 Preparation of recombinant rotavirus proteins in milk of transgenic non human mammals
09/15/2005WO2005084410A2 Compositions and methods for topical application and transdermal delivery of botulinum toxins
09/15/2005WO2005084355A2 Insecticidal toxin complex fusion proteins
09/15/2005WO2005084198A2 Peptides of il1 beta and tnf alpha and method of treatment using same
09/15/2005WO2005084190A2 Methods and compostions for targeted cleavage and recombination
09/15/2005WO2005084179A2 Improved method for preparing conjugates of proteins and chelating agents
09/15/2005WO2005084158A2 Polypeptide transduction and fusogenic peptides
09/15/2005WO2005084116A2 Calcium channel variants
09/15/2005WO2005067958A3 Methods and compositions for the inhibition of cathepsins
09/15/2005WO2005063990A3 Wuschel (wus) gene homologs
09/15/2005WO2005056569A3 Beta integrin gene and protein
09/15/2005WO2005054284A3 Regulation involving abin-2
09/15/2005WO2005052003A3 Use of antibodies to the gamma 2 chain of laminin 5 to inhibit tumor growth and metastasis
09/15/2005WO2005049084A3 Inhibition of trp channels as a treatment for cardiac hypertrophy and heart failure
09/15/2005WO2005047316A3 Insulin releasing peptides
09/15/2005WO2005044982A3 Monomeric recombinant mhc molecules useful for manipulation of antigen-specific t cells
09/15/2005WO2005040195A3 Formulation of exendins
09/15/2005WO2005038001A3 Improved transgenesis by sperm-mediated gene transfer
09/15/2005WO2005034841A3 Anthrax vaccine
09/15/2005WO2005029088A3 Diagnostic method for brain damage-related disorders
09/15/2005WO2005028676A3 Method of diagnosing breast cancer
09/15/2005WO2005026209A3 Monoclonal antibodies against hmgb1
09/15/2005WO2005026199A3 Piroplasmid vaccine
09/15/2005WO2005023837A3 Ebola peptides and immunogenic compositions containing same
09/15/2005WO2005019249A3 Identification of porphyromonas gingivalis virulence polynucleotides for diagnosis, treatment, and monitoring of periodontal diseases
09/15/2005WO2005016962A3 Compositions and methods for the treatment of immune related diseases
09/15/2005WO2005016232A3 Therapeutic monoclonal antibodies that neutralize botulinum neurotoxins
09/15/2005WO2005007663A9 Fluorogenic enzyme substrates and uses thereof
09/15/2005WO2005005643A3 Chloroplast transformation of duckweed
09/15/2005WO2005003720A3 Method of detecting the cystic fibrosis transmembrane conductance regulator (cftr) at cell exterior
09/15/2005WO2005000895A3 Vegf traps and therapeutic uses thereof
09/15/2005WO2005000099A3 BLOOD FACTOR DOMAINS (BFDs)
09/15/2005WO2004111200A3 Rtvp-glipr-like compositions and methods for the detection, treatment and prevention of prostate cancer
09/15/2005WO2004111086A3 Peptide analogues comprising at least one type of aminoacyl aza-$g(b)3 and the use thereof, in particular for therapy
09/15/2005WO2004110372A3 Room temperature storage of organs
09/15/2005WO2004094472A3 Collagen fibrils carrying bioactive heterologous domains and their use in e.g. wound healing
09/15/2005WO2004094461A3 Human glucagon-like-peptide-1 mimics and their use in the treatment of diabetes and related conditions
09/15/2005WO2004093810A3 Methods and compositions for treating disorders
09/15/2005WO2004089284A3 Targets for tumor growth inhibition
09/15/2005WO2004085461A3 Tumour-associated peptides binding to mhc molecules
09/15/2005WO2004084711A3 Methods of detecting neurological disorders
09/15/2005WO2004073415A3 Water soluble animal muscle protein product
09/15/2005WO2004065580A3 Mesecnhymal stem cells as a vehicle for ion channel transfer in syncytial structures
09/15/2005WO2004050852A3 Recombinant polypeptides for diagnosing infection with trypanosoma cruzi
09/15/2005WO2004050832A3 Antimicrobial compounds from bacillus subtilis for use against animal and human pathogens
09/15/2005WO2004037993A3 Methods of producing a library and methods of selecting polynucleotides of interest
09/15/2005WO2004020586A3 Beta-2 microglobulin (b2m) and b2m related gene products for the regulation of osteoarthritis pathogenesis and chondrocyte proliferation
09/15/2005WO2004015078A3 Methods and materials relating to novel growth regulatory-like polypeptides and polynucleotides
09/15/2005WO2003106657A3 Wise/sost nucleic acid sequences and amino acid sequences
09/15/2005WO2003085087A8 Modified cea nucleic acid and expression vectors
09/15/2005WO2003076590A3 Arrestin gene, polypeptide and methods of use thereof
09/15/2005WO2003060473A3 Mucin immobilized chromatography
09/15/2005WO2003000844A3 Protein modification and maintenance molecules
09/15/2005WO2002048388A3 Method of inhibiting infection by hcv, other flaviviridae viruses, and any other virus that complexes to low density lipoprotein or to very low density lipoprotein in blood preventing viral entry into a cell
09/15/2005US20050204435 Plant recombination proteins
09/15/2005US20050204431 Use of specific myb genes for the production of transgenic plants tolerant to biotic and abiotic stresses
09/15/2005US20050204430 Genetic engineering salt tolerance in crop plants
1 ... 1154 1155 1156 1157 1158 1159 1160 1161 1162 1163 1164 1165 1166 1167 1168 1169 1170 1171 1172 1173 1174 ... 2916